Stimulation of avian myoblast differentiation by triiodothyronine: possible involvement of the cAMP pathway.
In a previous work, we have shown that T3 induces a potent stimulation of avian myoblast differentiation. In this study, we demonstrated that this hormone did not affect MyoD and myogenin expression. As numerous data suggest that T3 could affect the cAMP pathway, we have studied its involvement in the myogenic activity of triiodothyronine on quail myoblast. In agreement with Zalin and Montagues (Cell 2, 103-108 (1974)), we observed a transient rise in myoblast intracellular cAMP level some hours before the onset of terminal differentiation. Interestingly, this rise occurred earlier in T3-treated than in control myoblasts, and cAMP production was significantly increased by the hormone. Moreover, T3 increased CREB transcriptional activity, thus suggesting that the entire cAMP signaling pathway was stimulated by this hormone. In addition, we observed that addition of an inhibitor of adenylate cyclase activity prior to the cAMP rise dramatically inhibited myoblast differentiation. Last, we showed that cAMP mimicked all T3 actions upon myoblast differentiation: (1) T3 and cAMP reduced myoblast proliferation by increasing the number of postmitotic myoblasts at cell confluence; (2) T3 and cAMP increased BTG1 nuclear accumulation; (3) T3 and cAMP stimulated terminal differentiation only when added during the proliferative phasis. These data strongly suggest that the transient rise in cAMP production could be essential for myoblast terminal differentiation. In addition, it appears that, at least in avian myoblasts, T3 stimulation of terminal differentiation involves the cAMP pathway.
Marchal
S
S
Laboratoire de Différenciation Cellulaire et Croissance, INRA, Montepellier, France.
Cassar-Malek
I
I
Magaud
J P
JP
Rouault
J P
JP
Wrutniak
C
C
Cabello
G
G
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002459:Cell Fusion; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism*; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental; D007097:Imines / Q000494:pharmacology; D010369:Pectoralis Muscles / Q000166:cytology / Q000187:drug effects / Q000196:embryology*; D011784:Quail / Q000196:embryology*; D015398:Signal Transduction; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects; D014158:Transcription, Genetic; D014284:Triiodothyronine / Q000494:pharmacology*
D017362:Cyclic AMP Response Element-Binding Protein; D007097:Imines; D014284:Triiodothyronine; D015124:8-Bromo Cyclic Adenosine Monophosphate; C014925:RMI 12330A; D000242:Cyclic AMP